GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AddLife AB (CHIX:ALIFBs) » Definitions » Debt-to-Asset

AddLife AB (CHIX:ALIFBS) Debt-to-Asset : 0.42 (As of Sep. 2024)


View and export this data going back to 2016. Start your Free Trial

What is AddLife AB Debt-to-Asset?

AddLife AB's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was kr1,403 Mil. AddLife AB's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was kr4,034 Mil. AddLife AB's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Sep. 2024 was kr12,943 Mil. AddLife AB's debt to asset for the quarter that ended in Sep. 2024 was 0.42.


AddLife AB Debt-to-Asset Historical Data

The historical data trend for AddLife AB's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AddLife AB Debt-to-Asset Chart

AddLife AB Annual Data
Trend Mar14 Mar15 Mar16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.27 0.19 0.39 0.43 0.42

AddLife AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.42 0.42 0.42 0.41 0.42

Competitive Comparison of AddLife AB's Debt-to-Asset

For the Medical Instruments & Supplies subindustry, AddLife AB's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AddLife AB's Debt-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AddLife AB's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where AddLife AB's Debt-to-Asset falls into.



AddLife AB Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

AddLife AB's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

AddLife AB's Debt-to-Asset for the quarter that ended in Sep. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AddLife AB  (CHIX:ALIFBs) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


AddLife AB Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of AddLife AB's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


AddLife AB Business Description

Traded in Other Exchanges
Address
Brunkebergstorg 5, Box 3145, Stockholm, SWE, 103 62
AddLife AB is engaged in the business of providing products, services, and advisory services. The company operates in two segments: Labtech and Medtech segments. The Labtech segment, which accounts for the majority of the company revenue, provides analytical instruments, equipment, microscopes, consumables, and reagents, as well as software support and technical service. The Medtech segment includes products related to surgery, thoracic medicine, neurology, wound care, anesthesia, intensive care, ear, nose and throat, ostomies, and home healthcare. AddLife mainly caters to hospitals & laboratories within healthcare, research, colleges, and universities, as well as the food and pharmaceutical industries. Its geographical segments are Sweden, Denmark, Finland, Norway, and Other countries.

AddLife AB Headlines

No Headlines